Showing results (271-280 of 548) with videos related to
Sort By:
Pageof 55
Dermatology and Therapy|April 22, 2025
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records DatabaseAdina R Lemeshow, Alexander Egeberg, Thomas Edwards, et al.Dermatology and Therapy|September 24, 2022
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, et al.Journal of the American Academy of Dermatology|December 22, 2019
Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysisKevin R Patel, Harrison H Lee, Supriya Rastogi, et al.Archives of Dermatological Research|November 16, 2020
Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysisTammy Hua, Muhammad Yousaf, Eran Gwillim, et al.The Patient|May 13, 2025
Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA)Jonathan I Silverberg, Dina Filipenko, Carla Dias Barbosa, et al.The Journal of Investigative Dermatology|November 10, 2021
Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire-Child (PIQ-C) to Measure the Impact of Itch on Life QualityAmy S Paller, Jin-Shei Lai, Kathryn Jackson, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 8, 2021
Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysisMette Hjorslev Knudgaard, Thomas Holger Andreasen, Nanna Ravnborg, et al.American Journal of Clinical Dermatology|October 7, 2023
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1Eric L Simpson, Andrew Blauvelt, Jonathan I Silverberg, et al.Dermatology and Therapy|September 25, 2023
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical TrialsHannah Penton, Sayeli Jayade, Santhani Selveindran, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2017
Phenotypical Differences of Childhood- and Adult-Onset Atopic DermatitisJonathan I Silverberg, Paras P Vakharia, Rishi Chopra, et al.Pageof 55